R&D | March 19, 2026
IIT Roorkee unveils cutting-edge molecular medicine facility
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Subscribe To Our Newsletter & Stay Updated
